CXCL9 Protein

Produktnummer ABIN935629

Recombinant CXCL9-Protein exprimiert in Escherichia coli (E. coli).

Kurzübersicht für CXCL9 Protein (ABIN935629)

Target: CXCL9 (gamma-Interferon-Induced Monokine (CXCL9))

Protein-Typ: Recombinant

Biologische Aktivität: Active

Spezies: Maus

Quelle: Escherichia coli (E. coli)

Reinheit: > 98 % pure

Produktdetails

Sequenz: TLVIRNARCS CISTSRGTIH YKSLKDLKQF APSPNCNKTE IIATLKNGDQ TCLDPDSANV KKLMKEWEKK INQKKKQKRG KKHQKNMKNR KPKTPQSRRR SRKTT

Produktmerkmale: Purified recombinant Mouse MIG protein
Expression System: E.coli
Bioactivity: Determined by its ability to chemoacttract human lymphoytes using a concentration range of 0.1-1.0 ng/mL.

Endotoxin-Niveau: < 0.1 ng per µg (1 EU/µg).

Anwendungsinformationen

Applikationshinweise: Each Investigator should determine their own optimal working dilution for specific applications.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Buffer: Lyophilized from 10 mM CH3COOH.

Handhabung: Avoid repeated freeze/thaw cycles.

Lagerung: RT/-20 °C

Antigendetails

Target: CXCL9 (gamma-Interferon-Induced Monokine (CXCL9))

Andere Bezeichnung: MIG

Hintergrund: MIG, a CXC chemokine, is produced by IFN?× stimulated monocytes, macrophages and endothelial cells. It signals through the CXCR3 receptor. MIG selectively chemoattracts Th1 lymphocytes, and also exerts other activities including inhibition of tumor growth, angiogenesis, and inhibition of colony formation of hematopoietic progenitors. Human MIG is active on Mouse cells.
Alternative Names: Monokine Induced by Interferon-gamma protein, CXCL9 protein

Molekulargewicht: 12.2 kDa